Biodesix, Inc. BDSX Equity Financing Costs Included In Accounts Payable And Other Accrued Liabilities
Equity Financing Costs Included In Accounts Payable And Other Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept bdsx:EquityFinancingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s equity financing costs included in accounts payable and other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s equity financing costs included in accounts payable and other accrued liabilities?
- Biodesix, Inc. (BDSX) reported equity financing costs included in accounts payable and other accrued liabilities of $64K in Q1 2026.
- How has Biodesix, Inc.'s equity financing costs included in accounts payable and other accrued liabilities changed year-over-year?
- Biodesix, Inc.'s equity financing costs included in accounts payable and other accrued liabilities increased by 3557.1% year-over-year, from $1.75K to $64K.
- What does equity financing costs included in accounts payable and other accrued liabilities mean?
- This represents the portion of equity financing costs that have been accrued but not yet paid in cash at the end of the reporting period. It highlights the timing difference between the recognition of financing expenses and the actual cash outflow. Tracking this provides a more accurate picture of the total cost of capital raises and short-term liabilities.